Klinisk Biokemi i Norden · 2 2017
| 19
Is it worth the trouble? Arch Intern Med
2012;172:1710-2.
10. Nordestgaard BG, Hilsted L, Stender S.
Plasmalipider hos ikkefastende patienter og
signalv.rdier p. laboratoriesvar. Ugeskr Laeger
2009;171:1093.
11. Langsted A, Nordestgaard BG. Nonfasting
lipids, lipoproteins, and apolipoproteins in
individuals with and without diabetes: 58 434
individuals from the Copenhagen General
Population Study. Clin Chem 2011;57:482-9.
12. NICE clinical guideline CG181. Lipid modifi-
cation: Cardiovascular risk assesment and the
modification of blood lipids for the primary
and secondary prevention of cardiovascular
disease.
nice org uk/guidance/
cg181/evidence/lipid-modification-update-full-
guideline- 243786637 2015;Accessed 24-10-
2015:1-302.
13. Nordestgaard BG, Chapman MJ, Ray K, Boren
J, Andreotti F, Watts GF, et. al. Lipoprotein(a)
as a cardiovascular risk factor: current status.
Eur Heart J 2010;31:2844-53.
14. Chapman MJ, Ginsberg HN, Amarenco P,
Andreotti F, Boren J, Catapano AL, et. al. Tri-
glyceriderich lipoproteins and high-density
lipoprotein cholesterol in patients at high risk of
cardiovascular disease: evidence and guidance
for management. Eur Heart J 2011;32:1345-61.
15. Reiner Z, Catapano AL, De BG, Graham I,
TaskinenMR, WiklundO, et. al. ESC/EAS Gui-
delines for the management of dyslipidaemias:
the Task Force for the management of dyslipi-
daemias of the European Society of Cardiology
(ESC) and the EuropeanAtherosclerosis Society
(EAS). Eur Heart J 2011;32:1769-1818.
16. Miller M, Stone NJ, Ballantyne C, Bittner V,
Criqui MH, Ginsberg HN, et. al. Triglycerides
and cardiovascular disease: a scientific state-
ment from the American Heart Association.
Circulation 2011;123:2292-333.
17. Perk J, De Backer G, Gohlke H, Graham I,
Reiner Z, Verschuren M, et. al. European Gui-
delines on cardiovascular disease prevention in
clinical practice (version 2012). The Fifth Joint
Task Force of the European Society of Car-
diology and Other Societies on Cardiovascular
Disease Prevention in Clinical Practice (consti-
tuted by representatives of nine societies and by
invited experts). Eur Heart J 2012;33:1635-701.
18. Friedewald WT, Levy RI, Fredrickson DS.
Estimation of the concentration of low-density
lipoprotein cholesterol in plasma, without use
of the preparative ultracentrifuge. Clin Chem
1972;18:499-502.
19. Tanno K, Okamura T, Ohsawa M, Onoda T, Itai
K, Sakata K, et. al. Comparison of lowdensity
lipoprotein cholesterol concentrations mea-
Foto: Henrik Alfthan.
